There are multiple indications that Complementary Medicine is here to stay. Growing awareness of the benefits of natural therapies, the convenience of buying medicines off-the-shelf, rising health insurance costs, and increasing incidence of adverse reports of the side-effects that mainstream prescription medicine can entail are some of the reasons people use for choosing Complementary Medicine. Many physicians support such self-care forms for certain chronic ailments.

Quality Assurance is a major hurdle which prevents the business expansion of Complementary Medicine. Illicit transactions on the Internet, and the absence of adequate regulations in exotic countries where many of these remedies are made, give such products a bad overall image. The US Food and Drug Administration officials treat many of these products as dietary supplements, and thereby avoids due assessment and certification of these products. People at large and their physicians are therefore deterred by a paucity of reliable sources of supply.

Here is a stock that conveys all the major benefits of Complementary Medicine in a reliable format. The stock trades on the Australian Stock Exchange, which is evidence that the management follows international disclosure, reporting, and governance guidelines.

An additional advantage of Complementary Medicine stock from Australia is that the country has comprehensive regulations covering the production and other business aspects of such products. This company’s products are from the Australian Register of Therapeutic Goods, and are made under Good Manufacturing Practices (GMP).

The company has been in business for over half a century. It has growing market shares in the Asia-Pacific region. The net profit margin for the last four quarters is nearly 10% and the return on average equity is over 41%.

Let us hear your thoughts below: